Co-occurring medical and substance use disorders in patients with schizophrenia: a systematic review

Reference

• Abd. Rashid, A., Robson, N., Sulaiman, A. H., Salleh, R., Zainal, N. Z., Said, M. A., & Habil, H. (2010). Schizophrenia, substance use and aggressions: what are the relationships? ASEAN Journal of Psychiatry, 11(1), 77–83.
   Google Scholar
• American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. (4th Ed.). Washington, DC: American Psychiatric Press.
   Google Scholar
• Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001). Substance abuse in schizophrenia: A review of the literature and a study of correlates in Sweden. Schizophrenia Research, 48(1), 69–82. doi:10.1016/s0920-9964(00)00114-6.
   PubMed Web of Science ®Google Scholar
• Cent. Subst. Abuse Treat (2005). Substance abuse treatment forpersons with co-occurring disorders. TreatmentImprovement Protocol (TIP) Ser., No. 42. DHHS Publ. No. (SMA) 05–3992. Rockville, MD: Subst. Abuse Ment. Health Serv. Admin.
   Google Scholar
• Dalack, G. W., Healy, D. J., & Meador-Woodruf, J. H. (1998). Nicotine dependence in Schizophrenia: Clinical phenomena and laboratory findings. American Journal of Psychiatry, 155(11), 1490–1150. doi:10.1176/ajp.155.11.1490.
   PubMed Web of Science ®Google Scholar
• Dervaux, A., Baylé, F. J., Laqueille, X., Bourdel, M. C., Le Borgne, M. H., Olié, J. P., & Krebs, M. O. (2004). Nicotine in schizophrenia and disinhibition. Journal of Psychiatry Research, 238(1), 229–234. doi:10.1016/j.psychres.2004.05.021.
   Web of Science ®Google Scholar
• Dervaux, A., Laqueille, X., Bourdel, M. C., Le Borgne, M. H., Olié, J. P., & Krebs, M. O. (2003). Cannabis and schizophrenia: demographic and clinical correlates. Encephale, 29(1), 11–17. doi:ENC-2-2003-29-1-0013-7006-101019-ART2.
   PubMed Web of Science ®Google Scholar
• Duko, B., Ayano, G., Bekana, L., & Assefa, D. (2015). Prevalence and correlates of co-occurring substance use disorder among patients with severe mental disorder at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia. J Neuropsychopharmacol Mental Health, 1(1), 2015. doi:10.4172/2472-095X.1000101.
   Google Scholar
• Fountoulakis, K. N., Siamouli, M., Panagiotidis, P., Magiria, S., Kantartzis, S., Papastergiou, N., … Deres, S. (2010). Obesity and smoking in patients with schizophrenia and normal controls: A case-control study. Psychiatry Research, 176(1), 13–16. doi:10.1016/j.psychres.2008.11.018.
   PubMed Web of Science ®Google Scholar
• Hert, M. D., Correll, H. C., & BoBes, J. U. (2011). Physical illness in patients with severe mental disorders.I. Prevalence, impact of medications and disparitiesin health care. World Psychiatry, 10, 52–77. doi:10.1002/j.2051-5545.2011.tb00014.x.
   PubMed Web of Science ®Google Scholar
• Holt, R. G., & Peveler, R. C. (2010). Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future. Practical Diabetes International, 27(2), 79–84.
   Google Scholar
• Holt, R. I. G., Abdelrahman, T., Hirsch, M., Dhesi, Z., George, T., Blincoe, T., & Peveler, R. C. (2010). The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. Journal of Psychopharmacology, 24(6), 867–873. doi:10.1177/0269881109102788.
   PubMed Web of Science ®Google Scholar
• Hung C, C.-K., & Wua, P.-Y. (2005). Diabetes mellitus in patients with schizophrenia in Taiwan. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 523–527. doi:10.1016/j.pnpbp.2005.01.003.
   PubMed Web of Science ®Google Scholar
• Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Prevalence of alcohol use disorders in schizophrenia – a systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 120(2), 85–96.
   Google Scholar
• Nesvåg, R., Knudsen, G. P., Bakken, I. J., Høye, A., Ystrom, E., Surén, P., … Reichborn-Kjennerud, T. (2015). Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Social Psychiatry and Psychiatric Epidemiology, 50(8), 1267. doi:10.1007/s00127-015-1025-2.
   PubMed Web of Science ®Google Scholar
• Rane, A., Nadkarni, A., Kanekar, J., Fernandes, W., Borker, H. A., & Pereira, Y. (2012). Alcohol use in schizophrenia: prevalence, patterns, correlates and clinical outcomes in Goa, India. The Psychiatrist, 36(07), 257–262. doi:10.1192/pb.bp.111.036459.
   Google Scholar
• Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA, 264(19), 2511–2518. doi:10.1001/jama.264.19.2511.
   PubMed Web of Science ®Google Scholar
• Robson, D., & Gray, R. (2007). Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies, 44(3), 457–466. doi:10.1016/j.ijnurstu.2006.07.013.
   PubMed Web of Science ®Google Scholar
• Soyka, M., Albus, M., Kathmann, N., Finelli, A., Hofstetter, S., Holzbach, R., … Sand, P. (1993). Prevalence of alcohol and drug abuse in schizophrenic inpatients. European Archives of Psychiatry and Clinical Neuroscience, 242(6), 362–372.
   PubMed Web of Science ®Google Scholar
• Suriyong, J., Viboonma, K., Keawma, P., Khamwongpin, M., & Tamdee, D. (2014). Prevalence of alcohol use disorders of schizophrenic patients at the inpatient and outpatient department of Suan Prung psychiatric hospital. Journal of Mental Health of Thailand, 22(1). doi:10.14456/dmhjournal.2014.4.
   Google Scholar
• Swofford, C. D., Scheller-Gilkey, G., Miller, A. H., Woolwine B., & Mance R. (2000). Schizophrenia and substance use. The American Journal of Drug and Alchol Abuse, 26(3). https://doi.org/10.1081/ADA-100100248
   PubMed Web of Science ®Google Scholar
• Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009). Defining comorbidity: Implications for understanding health and health services, Annals of Family Medicine, 7(4), 357–363. doi:10.1370/afm.983.
   PubMed Web of Science ®Google Scholar
• Veling, W., Mackenbach, J. P., van Os, J., & Hoek, H. W. (2008). Cannabis use and genetic predisposition for schizophrenia: a case-control study. Journal of Psychosomatic Medicine, 38(9), 1251–1256. doi:10.1017/s0033291708003474.
   Web of Science ®Google Scholar
• Verdoux, H., Mury, M., Besançon, G., & Bourgeois, M. (1996). Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders. Encephale, 22(2), 95–101.
   PubMed Web of Science ®Google Scholar
• Vinogradov, Y., Coupland, C., Hippisley-Cox, J., Whyte, S., Penny, C. (2010). Effects of severe mental illness on survival of people with diabetes. British Journal of Psychiatry, 197, 272–277. doi:10.1192/bjp.bp.109.074674.
   PubMed Web of Science ®Google Scholar
• Winklbaur, B., Ebner, N., Sachs, G., Thau, K., Fischer, G. (2006). Substance abuse in patients with schizophrenia. Dialogues in Clinical Neuroscience, 8(1), 37–43.
   Google Scholar